Sunil Mutgi
Neurology · Sheridan, WYNPI 1225358906
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 74 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$279
- Otsuka America Pharmaceutical, Inc.$194
- TG Therapeutics, Inc.$162
- Alkermes, Inc.$143
- Lilly USA, LLC$121
- Collegium Pharmaceutical, Inc.$74
- plus $638 from 21 others
What the payments were for
- Food & beverage$1,57898%
- Education$322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $279 |
| Otsuka America Pharmaceutical, Inc. | 9 | $194 |
| TG Therapeutics, Inc. | 9 | $162 |
| Alkermes, Inc. | 2 | $143 |
| Lilly USA, LLC | 2 | $121 |
| Collegium Pharmaceutical, Inc. | 4 | $74 |
| Acadia Pharmaceuticals Inc | 3 | $74 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| Tris Pharma Inc | 3 | $48 |
| Johnson & Johnson(2 entities) | 2 | $46 |
| Genentech USA, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $33 |
| Novo Nordisk | 1 | $32 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Biogen | 2 | $29 |
| UCB, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Argenx US, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Pfizer | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$463
How this compares
Too few neurology providers in Wyomingto place this figure against a meaningful peer group, so we don't.
Other neurology in Sheridan
- Thomas MayerSheridan$8K
- Allen GeeCody$8K
- Mary KerberCheyenne$3K
- David WheelerCasper$2K
- Tracie CallerCheyenne$2K
- Angelo SantiagoCasper$2K
- Prachi PawarRock Springs$1K
- Liam ClarkCheyenne$524
- Vinay Bhushan Reddy LakkiGillette$431
- Celina TolgeCheyenne$75
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.